You are viewing the site in preview mode
Skip to main content
| |
TRUVADA
| | | |
KIVEXA
| | | |
|---|
| |
All (mean 122,106)
|
VL >100,000 (mean 263,684)
|
VL 10–100,000 (mean 45, 772)
|
VL <10,000 (mean 5243)
|
All (mean 99,883)
|
VL > 100,000 (mean 256,364)
|
VL 10–100,000 (mean 48, 221)
|
VL < 10,000 (mean 6214)
|
|---|
|
Number of patients
|
53
|
20
|
23
|
10
|
33
|
9
|
20
|
4
|
|
VL <50 at 3 months (%)
|
60
|
35
|
74
|
80
|
73
|
60
|
80
|
75
|
|
Vl < 50 at 4 months (%)
|
75
|
60
|
87
|
90
|
79
|
78
|
85
|
75
|
|
VL < 50 at 6 months (%)
|
83
|
80
|
91
|
90
|
91
|
89
|
90
|
100
|
|
VL < 1000 at 4 weeks (%)
|
67
|
45
|
83
|
70
|
70
|
22
|
85
|
100
|
